has been cited by the following article(s):
[1]
|
A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
International Journal of Molecular Sciences,
2021
DOI:10.3390/ijms22062865
|
|
|
[2]
|
Lipocalin-2: A novel diagnostic marker for hepatocellular carcinoma
Cancer Biomarkers,
2020
DOI:10.3233/CBM-190084
|
|
|
[3]
|
Exploiting bilosomes for delivering bioactive polysaccharide isolated from Enteromorpha intestinalis for hacking hepatocellular carcinoma
Drug Development and Industrial Pharmacy,
2017
DOI:10.1080/03639045.2017.1402922
|
|
|
[4]
|
Altered mitochondrial and peroxisomal integrity in lipocalin-2-deficient mice with hepatic steatosis
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease,
2017
DOI:10.1016/j.bbadis.2017.04.006
|
|
|
[5]
|
Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy
Frontiers in Physiology,
2016
DOI:10.3389/fphys.2016.00430
|
|
|
[6]
|
Serological tumor markers of hepatocellular carcinoma: a meta-analysis
The International Journal of Biological Markers,
2015
DOI:10.5301/jbm.5000119
|
|
|
[7]
|
Lipocalin 2 in the pathogenesis of fatty liver disease and nonalcoholic steatohepatitis
Clinical Lipidology,
2015
DOI:10.2217/clp.14.65
|
|
|
[8]
|
Oxidative Role of Aflatoxin B1 on the Liver of Wheat Milling Workers
Open Access Macedonian Journal of Medical Sciences,
2014
DOI:10.3889/oamjms.2014.026
|
|
|